Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe two screenshots show the same Study Details page for NCT04191304 with no additions or deletions observed. Core sections such as design, eligibility criteria, and location lists remain unchanged.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedVersion updated from v3.0.2 to v3.2.0; no substantive content changes detected.SummaryDifference0.1%

- Check40 days agoChange DetectedUpgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved several MedlinePlus drug-safety topics from the page, narrowing the range of covered drug-related subjects.SummaryDifference0.3%

- Check55 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release/patch. The 'Back to Top' UI element was removed, a minor UI change.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.